Bristol Myers Squibb (BMS) has yet to announce official presentation plans at the 44 th annual JP Morgan Healthcare Conference, although Karin Shanahan, EVP, chief supply chain and operations officer, ...
Hyderabad: Union Minister of State for Home Affairs Bandi Sanjay Kumar participated in the inauguration ceremony of the newly ...
Bristol-Myers Squibb Company ($BMY) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb (BMY) has launched a ...
For H1 2025 Lloyd’s posted a £4.2bn ($5.6bn) H1 profit before tax which Tiernan called a “solid half-year performance, demonstrating strength and resilience”. This was down £700mn year on year, as ...
Yet, many medical affairs teams remain bound to traditional workflows. Linear processes and siloed functions are struggling ...
In a world of constant change, certain individuals do not merely adapt — they lead. These architects of the future are ...
It’s been another whirlwind year in the world of pharma marketing. | Updates on DTC advertising and DTP programs, as well as special reports, event coverage and, of course, news bulletins from the ...
XING Mobility will exhibit at CES 2026 in Las Vegas at the Las Vegas Convention Center, West Hall, Level 1, Booth #7059, ...
Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...
Bristol Myers Squibb's financial results haven't been great in recent years. The giant drugmaker has been facing challenges, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results